Identifying MGD in Young Patients - Summary - MDSpire

Identifying MGD in Young Patients

Digital device use, lifestyle factors, and modern beauty practices affect the growing rate of dry eye in pediatric patients.

  • By

  • Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

  • 5 min

Share

Objective:

To discuss the prevalence and management of dry eye disease (DED) and meibomian gland dysfunction (MGD) in younger populations, specifically children and young adults.

Approach:
    Key Findings:
    • 5.5% to 23% of the pediatric population (ages 5-18) in the U.S. is affected by DED.
    • 31% of affected children show severe meibomian gland atrophy.
    • Digital device use exceeding 2-3 hours daily significantly contributes to ocular surface changes.
    Interpretation:

    The increasing prevalence of MGD in younger populations necessitates early identification and tailored management strategies, particularly considering lifestyle and cosmetic product use.

    Limitations:
    • Lack of mandatory recall system for harmful cosmetic ingredients in the U.S. is significant as it limits consumer safety.
    • Only 11 harmful ingredients are banned, and not all need to be listed on product labels.
    Conclusion:

    Effective management of dry eye in younger patients requires consistent protocols, education, and accessibility to treatments, urging practitioners to adopt these strategies.

    Sources:

Original Source(s)

Identifying MGD in Young Patients

  • by Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

Related Content

Elevating Ocular Surface Care

The trilayer decellularized basement membrane is used in ocular surgery and in OSD applications, including corneal and conjunctival-related injuries or defects.

Dual Light Therapy Device for Dry Eye and OSD Management

Essilor Instruments' eye-light® delivers targeted, condition-specific management for ocular surface diseases

  • June 2, 2026

  • 2 min
Dry Eye Partnership Celebrates 5 Years

Optometric Management spoke with Alcon and the World Council of Optometry (WCO) on the 5-year partnership that is still going strong between the companies, dry eye and patient quality of life, and initiatives in developing resources.